Once-a-month treatment for multiple sclerosis gains US patent – inching Israeli pharma company closer to the market.
Only three years after going into business in Ness Ziona, Israel, Mapi Pharma has won a US patent for a promising drug in its pipeline – a slow-release form of glatiramer acetate for treating multiple sclerosis (MS) symptoms just once a month.....Read More - http://www.ms-uk.org/copaxone
Mapi pharma patents new MS drug
Mapi pharma patents new MS drug
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post